Cargando…
Duration of treatment with inhaled corticosteroids in nonasthmatic eosinophilic bronchitis: a randomized open label trial
BACKGROUND: Nonasthmatic eosinophilic bronchitis (NAEB) responds well to inhaled corticosteroids (ICS), while recurrence is common after discontinuing treatment. There are no data available to show whether treatment duration of ICS in patients with NAEB is related to recurrence. We aim to evaluate t...
Autores principales: | Zhan, Wenzhi, Tang, Jiaman, Chen, Xiaomei, Yi, Fang, Han, Lina, Liu, Baojuan, Luo, Wei, Chen, Qiaoli, Lai, Kefang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920589/ https://www.ncbi.nlm.nih.gov/pubmed/31847717 http://dx.doi.org/10.1177/1753466619891520 |
Ejemplares similares
-
Role of PGE(2) in Asthma and Nonasthmatic Eosinophilic Bronchitis
por: Sastre, Beatriz, et al.
Publicado: (2012) -
Clinical Outcome of Eosinophilic Airway Inflammation in Chronic Airway Diseases Including Nonasthmatic Eosinophilic Bronchitis
por: Cho, Jaeyoung, et al.
Publicado: (2018) -
Eotaxin and IL-4 levels are increased in induced sputum and correlate with sputum eosinophils in patients with nonasthmatic eosinophilic bronchitis
por: Zhang, Rui, et al.
Publicado: (2017) -
Efficacy of Add-on Montelukast in Nonasthmatic Eosinophilic Bronchitis: The Additive Effect on Airway Inflammation, Cough and Life Quality
por: Bao, Wuping, et al.
Publicado: (2015) -
Nonasthmatic eosinophilic bronchitis in an ulcerative colitis patient – a putative adverse reaction to mesalazine: A case report and review of literature
por: Cernomaz, Andrei Tudor, et al.
Publicado: (2020)